Jórunn Erla Eyfjörð | Academic Influence

Jórunn Erla Eyfjörð's AcademicInfluence.com Rankings

Jórunn Erla Eyfjörð

Biology

#15419

World Rank

#19392

Historical Rank

Computational Biology

#401

World Rank

#403

Historical Rank

Cell Biology

#887

World Rank

#910

Historical Rank

Genetics

#1923

World Rank

#2045

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Jórunn Erla Eyfjörð Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jórunn Erla Eyfjörð is an Icelandic molecular biologist and professor emerita at the Faculty of Medicine of the University of Iceland. She is known for her research on breast cancer genetics. Career Jórunn Erla matriculated from the mathematics division of Reykjavik Junior College in 1966. She did her undergraduate studies at the University of Iceland and University of Minnesota. She graduated with a BSc in biology from the University of Iceland in 1971. Along with her undergraduate studies she worked as an assistant to professor Gudmundur Eggertsson at his newly founded molecular genetics laboratory, at Keldur, Institute for Experimental Pathology. Jórunn continued her studies in molecular genetics at the MRC Cell Mutation Unit, University of Sussex, England, and completed her doctorate in 1976 on the topic of DNA repair, studying the processes by which a cell recovers from damage due to radiation.

(See a Problem?)

Jórunn Erla Eyfjörð's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Signatures of mutational processes in human cancer (2013) (7589)
Population-based study of risk of breast cancer in carriers of BRCA2 mutation (1998) (366)
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer (2014) (358)
Study of a single BRCA2 mutation with high carrier frequency in a small population. (1997) (313)
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes (2014) (289)
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains (1995) (206)
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo (2017) (204)
Screening for germ line TP53 mutations in breast cancer patients. (1992) (196)
BRCA2 mutation in Icelandic prostate cancer patients (1997) (145)
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. (1998) (140)
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. (1993) (127)
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. (2006) (127)
p53 abnormalities and genomic instability in primary human breast carcinomas. (1995) (107)
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. (1998) (89)
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells (2015) (75)
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis. (1995) (61)
Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short‐term culture (1995) (56)
TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material. (1996) (50)
A candidate CpG SNP approach identifies a breast cancer associated ESR1‐SNP (2011) (41)
Combined effect of low-penetrant SNPs on breast cancer risk (2011) (40)
Mutations in exons 5–8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma (1999) (33)
Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis (1997) (29)
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium. (1997) (28)
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome (2011) (28)
Mutagenic DNA repair in escherichia coli. V. Mutation frequency decline and error-free post-replication repair in an excision-proficient strain. (1977) (25)
BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts (2009) (24)
BRCA2 germline mutations in Swedish breast cancer families (1998) (23)
p53 abnormality and chromosomal instability in the same breast tumor cells. (2000) (22)
Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization. (1996) (20)
TP53 abnormalities and genetic instability in breast cancer. (1995) (16)
MYC amplification and TERT expression in breast tumor progression. (2007) (16)
Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients’ Clinical Outcome (2014) (15)
Corrigendum: Signatures of mutational processes in human cancer (2013) (13)
Mutagenic DNA repair in Escherichia coli: conditions for error-free filling of daughter strand gaps. (1975) (12)
Centriole movements in mammalian epithelial cells during cytokinesis (2010) (10)
Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers (2017) (7)
Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer (2012) (7)
Genetic changes in breast carcinomas in an Icelandic population. (1992) (6)
Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. (2016) (6)
Cytogenetic polyclonality of breast carcinomas : Association with Clinico‐Pathological Characteristics and Outcome (2011) (5)
Inbreeding and homozygosity in breast cancer survival (2015) (5)
Simultaneous detection of p53 nuclear protein and chromosome aberrations on sections from formalin-fixed, paraffin-embedded breast cancer tissue. (1998) (2)
Molecular genetics and cytogenetics of breast carcinomas: comparison of the two methods. (1996) (1)
deCODE deferred (1998) (0)
Tubio retrotransposition in cancer genomes Extensive transduction of nonrepetitive DNA mediated by L 1 (2014) (0)
BRCA2 Haploinsufficiency in Telomere Maintenance (2021) (0)

This paper list is powered by the following services:

Other Resources About Jórunn Erla Eyfjörð

en.wikipedia.org

What Schools Are Affiliated With Jórunn Erla Eyfjörð?

Jórunn Erla Eyfjörð is affiliated with the following schools:

University of Iceland

Image Attributions

Image Source for Jórunn Erla Eyfjörð